H Tilly

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

B. Coiffier, Corinne Haïoun, Nicolas Ketterer et al. · PubMed · 1998 · 896 citations

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

B Coiffier, Christian Gisselbrecht, Raoul Herbrecht et al. · Journal of Clinical Oncology · 1989 · 259 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +15

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

Pierre Fenaux, Sylvie Castaigné, Hervé Dombret et al. · Blood · 1992 · 234 citations · Full text

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

Y Bastion, Jean‐Yves Blay, Marine Diviné et al. · Journal of Clinical Oncology · 1997 · 209 citations

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.

P. Solal-Céligny, Pauline Brice, Nicole Brousse et al. · Journal of Clinical Oncology · 1996 · 146 citations